Oncopharmpod
ASCO VTE Guidelines (& more!)
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:26:52
- Mas informaciones
Informações:
Sinopsis
Updates on ASCO's updated VTE guidelines with a focus on prophylaxis for ambulatory cancer patients (1:15) and VTE treatment (12:50). Pembrolizumab's latest FDA-approval is discussed (16:00), as is pexidartinib's FDA-approval (18:00), and finally a comparison of BCOP pass rates by training status (22:34).
